Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback